Beroni Group cooperated with DENDRIX
The distinguished guests from Japan visited the company

Beroni Group cooperated with DENDRIX

On October 24,2017,the officers of DENDRIX visited Beroni Group. Beroni Group established a strategic partnership with DENDRIX on the development of human health projects such as immune cell medicine and stem cell fields.Mr. Shigeru Hirabayashi,CEO of DENDRIX,Mr.Katsuo Noguchi,CSO of DENDRIX and their officers attended this meeting.

Mr. Boqing Zhang send his respect to all the guests from Japan.Mr.Shigeru Hirabayashi,CEO of DENDRIX, introduced the strategic development plan of DENDRIX. He is looking forward to further strengthening cooperation and communication with Beroni Group. Mr.Katsuo Noguchi,CSO of DENDRIX,introduced the development of immunotherapy.

Mr. Boqing Zhang made a speech
Mr. Boqing Zhang made a speech
Mr.Shigeru Hirabayashi introduced the strategic development plan of DENDRIX. Mr.Katsuo Noguchi,introduced the development of immunotherapy
Mr.Shigeru Hirabayashi introduced the strategic development plan of DENDRIX. Mr.Katsuo Noguchi,introduced the development of immunotherapy

Beroni Group further understands the scientific breakthrough and development prospect of DENDRIX in immunotherapy field through friendly communication. The two sides have highly consistent in business philosophy and development goals.

Beroni Group and DENDRIX  have reached a long-term cooperation intention
Beroni Group and DENDRIX  have reached a long-term cooperation intention

Mr. Boqing Zhang said that the era of Precision Medicine has arrived, the clinical application of immune cell therapy will surely be the gospel of cancer patients.Beroni Group will built a platform for the immune cell therapy with DENDRIX, which will contribute to the development of health .

Close Menu